Skip to main content

Advertisement

SpringerLink
Log in

Resectable Hilar Cholangiocarcinoma: Surgical Treatment and Long-Term Outcome

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Unresected hilar cholangiocarcinoma has a dismal prognosis, but advances in staging and surgical techniques have given well-selected patients a chance of long-term survival if curative resection is possible. This review summarizes the state of the art in diagnosis, treatment, and outcome for patients with biliary obstruction at the hilus of the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Surgery, Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Michael I. D’Angelica, William R. Jarnagin & Leslie H. Blumgart

Authors
  1. Michael I. D’Angelica
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William R. Jarnagin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leslie H. Blumgart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Angelica, M., Jarnagin, W. & Blumgart, L. Resectable Hilar Cholangiocarcinoma: Surgical Treatment and Long-Term Outcome. Surg Today 34, 885–890 (2004). https://doi.org/10.1007/s00595-004-2832-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-004-2832-3

Key words

Search

Navigation